GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 113 filers reported holding GOSSAMER BIO INC in Q1 2023. The put-call ratio across all filers is 2.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,041,650 | +388.9% | 1,156,236 | +540.4% | 0.01% | +600.0% |
| Q1 2024 | $213,058 | -36.8% | 180,558 | -51.2% | 0.00% | -50.0% |
| Q4 2023 | $337,313 | +12.5% | 369,660 | +2.7% | 0.00% | 0.0% |
| Q3 2023 | $299,724 | -35.2% | 359,900 | -6.6% | 0.00% | -50.0% |
| Q2 2023 | $462,480 | -6.3% | 385,400 | -1.6% | 0.00% | -20.0% |
| Q1 2023 | $493,668 | -74.8% | 391,800 | -56.6% | 0.01% | -68.8% |
| Q4 2022 | $1,960,595 | +26.5% | 903,500 | +598.5% | 0.02% | +23.1% |
| Q3 2022 | $1,550,000 | +392.1% | 129,344 | +242.4% | 0.01% | +333.3% |
| Q2 2022 | $315,000 | -62.0% | 37,776 | -60.5% | 0.00% | -57.1% |
| Q1 2022 | $830,000 | -40.1% | 95,600 | -22.0% | 0.01% | -46.2% |
| Q4 2021 | $1,385,000 | +9.8% | 122,500 | +22.1% | 0.01% | 0.0% |
| Q3 2021 | $1,261,000 | +173.5% | 100,300 | +101.0% | 0.01% | +116.7% |
| Q1 2021 | $461,000 | +9.0% | 49,902 | +13.8% | 0.01% | 0.0% |
| Q4 2020 | $423,000 | – | 43,842 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,320,608 | $41,740,000 | 4.68% |
| Octagon Capital Advisors LP | 1,513,138 | $19,020,000 | 4.68% |
| Ally Bridge Group (NY) LLC | 1,175,000 | $14,770,000 | 4.34% |
| Parkman Healthcare Partners LLC | 786,870 | $9,891,000 | 2.50% |
| Palo Alto Investors LP | 1,772,950 | $22,286,000 | 1.34% |
| HHLR ADVISORS, LTD. | 7,420,974 | $93,282,000 | 1.22% |
| Ikarian Capital, LLC | 1,351,933 | $16,995,000 | 1.20% |
| Boxer Capital, LLC | 2,462,358 | $30,952,000 | 1.08% |
| ACUTA CAPITAL PARTNERS, LLC | 215,000 | $2,703,000 | 0.95% |
| EMERALD ADVISERS, LLC | 1,516,003 | $19,056,000 | 0.69% |